Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cytometry B Clin Cytom. 2015 Jan;88(1):69-73. doi: 10.1002/cyto.b.21173. Epub 2014 Apr 9.

A case of CD138-/CD19+/CD4+ IgD plasma cell leukemia.

Author information

  • 1IJC, Hospital Germans Trias i Pujol, Hematology Laboratory and Pathology Service, Badalona, Spain.

Abstract

BACKGROUND:

Plasma cell leukemia (PCL) is an uncommon and aggressive disease caused by the clonal proliferation of atypical plasma cells with phenotypical abnormalities similar to those seen in multiple myeloma (MM), although at different rates. Here, we report a case of IgD PCL with a very unusual CD138-/CD19+/CD4+ phenotype.

METHODS:

Peripheral blood and bone marrow samples from a 37-year-old patient afflicted by an aggressive plasma cell dyscrasia were examined and analyzed by conventional morphology, flow cytometry, and immunohistochemistry.

RESULTS:

Analysis of peripheral blood fulfilled criteria for PCL (more than 20% and more than 2 × 10e9 cells/L). However, flow cytometry and immunohistochemistry phenotyping revealed that the cells were CD138-/CD38+/CD19+/CD4+/CD56-/CD117-.

CONCLUSIONS:

PCL is diagnosed on peripheral blood smear. Immunophenotyping is a tool that can be helpful in diagnosing difficult cases but its atypical findings should not prevent the appropriate PCL diagnosis in clinically and morphologically unquestionable cases. © 2014 International Clinical Cytometry Society.

© 2014 Clinical Cytometry Society.

KEYWORDS:

CD138 negative; CD4 positive; plasma cell leukemia

PMID:
24715427
[PubMed - in process]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for John Wiley & Sons, Inc.
    Loading ...
    Write to the Help Desk